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ABSTRACT
The project was aimed to develop an easy and sensitive analytical tool to study the role of
fatty acids (FAs) profile in periprostatic adipose tissue (PPAT) and prostate cancer (PCa).

PCa

is the second leading cause of cancer-related death among American men. Although obesity has
been mostly ruled out by many researchers as a risk factor for developing PCa, it has shown to be
associated with PCa metastasis and progression. Periprostatic adipose tissue, which was present
on 48% of prostatic surfaces, has been reported to act as energy sources for facilitating a positive
microenvironment for PCa tumor progression. To understand the role of PPAT fatty acid profile
in relationship to PCa aggressiveness, this project was set out to develop a green method to analyze
the fatty acids (FAs) in adipose tissue using a solvent-less sample preparation technique, known
as stir-bar sorptive extraction, coupled with thermal desorption-Gas Chromatography/Mass
Spectrometry.
To detect FAs by Gas Chromatography-Mass Spectrometry, we used pork fat as the model
adipose tissue. FAs in pork fat were first subjected to transesterification. Several conditions to
optimize the transesterification process such as time, temperature, and acid amount in the solvent
mixture were studied. The best transesterification condition was found to be at 60-70 oC (regardless
of the heating methods, either in an oven or sonicator), with the reaction time of 1hr and using a
solvent mixture of CH3OH:HCl:CHCl3 (10:3:1, v/v/v). After transesterification, fatty acid methyl
esters (FAMEs) were extracted by stir bar sorptive extraction (SBSE). We studied factors that
could promote the extraction efficiency of FAMEs by SBSE. These factors included stirring
time, solvent addition, and stirring speed. We found that 1hr at 1500 RPM and no solvent addition
would give the best extraction efficiency of FAMEs. By estimate, the concentrations of FAMEs
detected in the fat samples ranged from 0.18 ppb (µg/L) to 114.82 ppb (µg/L). Therefore, the limit
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of detection for our method could be below 0.18 ppb (µg/L) for various FAMEs in fat tissue. The
sample preparation developed in this report has provided a green and sensitive alternative for the
study of FAs in adipose tissue, which will provide a valuable tool for future studies in the FAs
profile in PPAT and its impacts on PCa progression.
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CHAPTER 1 INTRODUCTION
1.1 Prostate Cancer Overview
Prostate cancer (PCa), according to the American cancer society, is the most commonly
diagnosed cancer among American men, with more than 191,930 new cases diagnosed and about
33,330 deaths reported in 2020.1 The numbers mean that 1 in 9 men will be diagnosed with PCa
and about 1 in 41 will die from the disease, making PCa the second leading cause of cancer death
among American men.2 The rising incidence in PCa through the past 30 years, could be attributed
to the improvement in testing awareness.3 Other factors, such as adipose tissue (AT), could also
play an important role in supporting metabolic changes happening in the tumor microenvironment
to support tumor growth.4 In a sense, PCa cells have become metabolically addicted to lipid
metabolism, for achieving successful carcinogenesis and survival.5–7 In a study done by Calle et
al. (2003) overweight and obesity in the United States were said to decrease survival rate among
all cancers and was estimated to account for 14% of all death from cancer in men.8

1.2 Prostate Cancer and Adipose Tissue
For a long time, AT was presumed to have no real relevance to biological processes in the
human body. Scientists thought of AT as another form of energy storage and temperature
regulation.9 Nevertheless, AT in the body has been lifted off of the shadows and recognized as an
active endocrine organ that secretes growth factors, chemokines, and proinflammatory molecules
(adipokines).9 AT in our body is divided into two categories: subcutaneous fat (underneath the
skin) and visceral fat (surrounding the organs). Only about 10% of AT is visceral fat. Nonetheless,
this type of body fat is one of the most metabolically active, which makes it of most interest for
many cancer studies.10 In the human body, the excessive accumulation of fat has been linked to a
1

variety of health problems that have detrimentally affected organs sensitive to metabolic changes,
encouraging the development and progression of a range of metabolic disorders.11,12
For prostate cancer, the narration between its correlation to adiposity has long been
debated. Some researchers have questioned whether high body mass index (BMI) is a risk factor
for developing PCa. MacInnis et al. (2006) reported that obesity was weakly related to the risk of
developing PCa.13 On the other hand, De Pergola et al. (2013) reported that obesity was related to
higher cancer risk through BMI, weight increase, visceral fat, and lifestyle factors.14 More recently,
Markozannes et al. (2016) reported that aspects of diet, adiposity, and physical activity may affect
PCa risk, yet, evidence was not concise enough to identify these aspects as risk factors for PCa.15
Other researchers have found stronger evidence that BMI is not related to PCa risk and rather is
related to PCa grade. Cao et al. (2011) reported that cancer-free people with high BMI had a higher
risk of dying from PCa if they developed the disease.16 Discacciati et al. (2012) reported that as
BMI increases, the risk of a localized PCa decreases, while a direct association with advanced PCa
was observed.17 Vidal et al. (2014) reported that BMI, independent of PSA levels and other clinical
covariates, is associated with a low risk of developing PCa, but a high risk of having a high-grade
non-localized more aggressive PCa.18 Lastly, Zhang et al. (2015) reported that obesity was
significantly associated with PCa aggressiveness and progression, thus increasing overall
mortality.19

1.3 Effect of Fatty Acid Profile in Cancer - It Is Not All About Quantity, it is Also About
the Quality
For a long time, BMI has been the main representation of adiposity and obesity in the
human body. However, BMI does not show a direct correlation between obesity in men and PCa
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aggressiveness.3,10 Research has reported that the volume of AT surrounding the prostate, known
as periprostatic adipose tissue (PPAT), has been significantly correlated to a high Gleason score,
which is indicative of an advanced stage of PCa.10 This is attributed to the extracapsular extension
of PCa into the PPAT and the vascularization of the prostate, which promotes paracrine
mechanisms for PCa progression.3,20 As people get older, the amount of bone marrow adiposity
increases, which tied to a large PPAT volume provides a pathway that fuels PCa cells to
metastasize in the bone.21 In an estimate, about 90% of the patients with an aggressive PCa develop
metastasis in the bone.9 Moreover, when looking at the composition of PPAT, it provides a better
understanding of the possible correlation between PCa and AT, linking to metabolic alterations
required for cancer cell survival.7
PPAT is composed of fatty acids (FAs) with different lengths of carbon chains and
saturation. The FAs in PPAT are stored within complex lipids such as ceramides, phospholipids,
diacylglycerol, and triacylglycerol.22 In visceral adipose tissue, the majority of FAs (75%) present
are oleate (C18:1), palmitate (C16:0), palmitoleate (C16:1), stearate (C18:0), and vacceneate (C19:1).23
Through paracrine mechanisms, PPAT provides PCa cells with FAs to fulfill metabolic
necessities.20 Also, as cancer progress and the demand for FA increases, de novo FA synthesis is
used by PCa cells to allow tumor proliferation and metastasis.5,9,22,24,25
In PCa, FAs are used for membrane synthesis (allowing cell growth and proliferation),
membrane saturation (providing oxidative stress resistance), lipid droplet formation (for survival
under energy stress), beta-oxidation (energy production), NADH oxidation (for redox balance),
and cholesterol lipid hormones (promoting cell proliferation and invasion).5,24–26 In the human
body, FA synthesis gives as main products palmitate (C16:0), myristate (C14:0), and stearate (C18:0).5
Further modifications, such as the addition of double bonds, or chain length increments take place
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in these FA and that can further benefit the tumor microenvironment for PCa cell proliferation.
For example, the elongation of FA chains is done by a family of elongates which add two carbons
at the end of a chain in each cycle of reactions.26 Tamura et al. reported that the overexpression of
ELOVL7 in PCa was involved in FA elongation of saturated very long chains (C20:0~) for the
formation of phospholipids, which are essential for membrane stabilization and raft formation
(signaling).27 Longer and more unsaturated fatty acids in human visceral fat are associated with
negative metabolic outcomes.23
Another modification is the degree of saturation or unsaturation of the FA chains.
Saturation (SFA) and mono-unsaturation (MUFA) of FAs by de novo lipogenesis are needed for
PCa cell membranes formation.

Zadra et al. has reported that, when compared to normal tissue,

PCa tumors showed an increase in the content of SFA and MUFA and a decrease in
polyunsaturated chains (PUFA).26 When lipid chains are saturated, they are more densely packed
which alters the membrane cell dynamics affecting, for instance, the efficacy of
chemotherapeutics.24,25 The saturation protects the cancerous cells from lipid peroxidation and
oxidative stress-induced cell death.5 However, the FA profile in PPAT of PCa is yet to be closely
investigated.

1.4 Current Analytical Methodologies for Fatty Acid Analysis
Lipids are often thought to be difficult to work with because of the complexity of the
nomenclature surrounding them, the poor understanding of their role in cell functions, and the lack
of methodologies for their study.28 To study FAs in lipid tissue, these compounds first must be
detached from their natural structure (Figure 1) through hydrolysis. After hydrolysis, free FAs
undergo transesterification, also known as methylation, to form Fatty Acid Methyl Esters
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(FAMEs). Contrary to FA, the apolar and semi-volatile structure of FAMEs allows for their
identification and quantification using Gas Chromatography (GC).29,30

Figure 1 An illustration showing the transesterification of FAs from lipids, triglyceride molecules.
A triglyceride molecule is formed of glycerol and three molecules of FAs. The
molecules of FAs forming the triglyceride can be of different length and have a
different amount of saturations. The FAMEs structures were obtained from
PubChem.31

Figure 2 summarizes some published methods for transesterification of FAs.29,32–35
Generally, the transesterification reaction of FAs can be accelerated with the use of a catalyst and
manipulation of other factors, such as temperature.36 The transesterification time and temperature
for most of the methodologies, ranges from 60-90 min and 90-100 °C, respectively.29,32–34 A strong
acid or a strong base is the common catalyst used in the reaction.37 In the method described by
Bligh and Dyer (1959), an excess of HCl is added to the sample before transesterification, and in
Lewis et al. (2000) HCl is part of the solvent mixture added to the sample before
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transesterification.29,33 Also, excessive alcohol is added as a way to push the reaction towards the
formation of FAMEs and glycerol, aiming for a 1:6 molar ratio of oil/alcohol.37

Figure 2 Diverse methodologies developed for the extraction, transesterification, and analysis of
FAMEs from biological samples.
Two of the main methodologies for the extraction and transesterification of FAs from tissue
samples were developed by Folch et al. (1957) and Bligh and Dyer (1959).32,33 (Figure 2) Other
methods, such as Lepage and Roy (1984) made use of a sample size in the milligram range instead
of the gram.34 Also, in Löfgren et al. (2016) the methodology was mostly automated, with the help
of a liquid handling system that facilitated the analysis of FAMEs using LC/MS.38 As shown in
6

Figure 2, these methods either require a large volume of organic solvents or are labor-intensive.
It is important to promote the use of green chemistry principles, such as the solvent-less sample
preparation technique, known as stir-bar sorptive extraction (SBSE), in advancing new
methodologies for the extraction and transesterification of FAs, as well as for the subsequent
extraction of FAMEs from the sample matrix.

1.5 Significance and Objectives
Diagnosing cancer staging is one of the main areas of interest in cancer research.39 The
correct staging of PCa patients is important to provide a proper evaluation, develop a personalized
treatment, and improve overall PCa prognosis for patients.40,41 PCa cells have adapted mechanisms
that ensure an optimal tumor microenvironment for cell survival and proliferation. Dietary and de
novo FAs are important for PCa cells since they are part of the energy, structural, and signaling
pathways. Many of these FAs are provided to PCa cells with the help of various molecules secreted
from PPAT. For example, FABP4 promotes the binding of long chains of FAs, which in turn can
be used in PCa cell membranes.12 It was hypothesized that the type of FA chains present in PPAT
is unique to the PCa tumor necessities, and in turn, the FA profile in PPAT could be a potential
tool for understanding the cancer metabolic microenvironment for PCa. The overarching goal of
our research is to use the FAs profile of the PPAT to develop an accurate staging tool for PCa. To
accomplish the goal, a fast and sensitive analytical tool is essential. This project was aimed to
develop a simple and solvent-less (i.e. green) method for the analysis of FAs profile in fat using
stir bar sorptive extraction (SBSE) and gas chromatography-mass spectrometry (GC-MS). We
hypothesized that by optimizing stirring time, speed, and solvent content of the sample matrix
during SBSE we can effectively extract the highly hydrophobic fatty acid methyl esters from the
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matrices and provide an overall more effective sample preparation process for the analysis of FAs
in fat. The optimized method will allow us to study the FAs profile and PCa stage, helping in the
understanding of the tumor microenvironment, and staging of the disease.

8

CHAPTER 2 METHODOLOGY
2.1 Chemicals and Reagents
Commercially available pork fat was used as the model adipose tissue for all
experiments. Pork fat was stored at 4°C until the preparation of the fat stock solution. Food
Industry Fatty Acid Methyl Ester (FAME) Mix (2%wt/wt) standard was purchased from
RESTEK Corporation (Bellefonte, PA). A list of the 37 FAMEs in the standard is included
in Appendix 1 and 2. The concentration of FAME primary stock solution was 2.6512×103
ppm (mg/L) in methanol (CH3OH, LC-MS Grade, Omni Solve Millipore Sigma, Billerica,
MA).
Mirex, as the internal standard, was purchased from Crescent Chemical (Islandia,
NY). Hydrochloric acid (HCl, 37% ACS grade) was purchased from Sigma Aldrich, Inc. (St.
Louis, MO). Chloroform was purchased from Fisher Scientific (Fair Lawn, NY). Acetonitrile
LC/MS grade was purchased from Fisher Chemical (Fair Lawn, NJ). Sodium Chloride
(NaCl), ACS reagent (>=99.0%) was purchased from Sigma Aldrich, Inc. (St. Louis, MO).
Deionized (DI) water was obtained using a Milli-Q system from Millipore (Bedford, MA,
USA).

2.2 Method Development
This methodology was developed following the diagram showed in Figure 3. The process
was divided into two main sections: sample preparation and sample analysis. The first part was
focused on fat sample handling, storage, homogenization, and transesterification parameters.
Sample analysis was centered around the extraction conditions and instrumentation parameters to
get an optimal separation, recovery, and identification of the analytes.
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Figure 3 A diagram describing the method development of this project. The two main areas of the
study are sample preparation and sample analysis. Each area subdivided into more
specific sections including all variables in this study.
2.2.1 Sample Preparation
Homogenization
This step aimed to achieve a homogeneous liquid fat stock sample. Pork fat was cut into
small portions and placed in a 15ml centrifuge tube. From there the tube was left for one day in a
Freeze Dry System (FreeZone 1 Liter Benchtop by LABCONCO, Kansas City, MO) to remove
any water from the fat. About 3 g of freeze-dried pork fat were weight and added into a small
beaker containing 90 ml of HCl:CHCl3 (9:1 v:v). Then the mixture was homogenized for 1hr using
Ultrasonic Homogenizer (Model 300V/T by BioLogics, Inc., Manassas, VA) at strength 80 and a
pulse of 30%. The sample was then decanted into a 50ml centrifuge tube and centrifuged for 15
min at 3000 rpm. After these, the sample was carefully decanted on to a new 50 ml centrifuge tube
and centrifuged for 10 min at 3500 rpm. These steps were to ensure that large fat particles were
removed in the final stock fat solution. Finally, the sample was carefully decanted into a clean 50
ml centrifuge tube and stored in the 10 °C fridge until the analysis.
10

Transesterification
To promote the detection of FAs by GC-MS, transesterification of the FA contained in the
stock pork fat was necessary prior to sample analysis. The transesterification procedure developed
in this project was inspired by Lewis et al. (2000).29 Optimization of transesterification to form
fatty acid methyl esters (FAMEs) is described as follows.

Heating Method by Oven (VWR International, 1326 Gravity Oven)
300 µL pork fat stock solution (10 mg) were added into a 15 ml centrifuge tube containing
3ml of CH3OH:HCl:CHCl3 ,10:3:1 ratio. The sample was left in the oven at a temperaturecontrolled between 60°C -70 °C for 2 hr. After transesterification was completed, the sample was
stored at 10 °C fridge until analysis.

Heating Method by Sonicator (Bransonic®, ultrasonic cleaner)
300 µL pork fat stock solution (10 mg) were added into a 15 ml centrifuge tube containing
3ml of CH3OH:HCl:CHCl3 ,10:3:1 ratio. Then the sample was left in the water bath on the
sonicator at a temperature fluctuating between 60°C -70°C for 1hr. After transesterification was
completed, the sample was stored at 10 °C fridge until analysis.

2.2.2 Sample Analysis
Stir Bar Sorptive Extraction (SBSE)
The basic steps of SBSE are illustrated in Figure 4.

Pre-conditioned GERSTEL

TwistersTM coated with polydimethylsiloxane (PDMS, 1 mm thickness, 10 mm length) were used
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to extract FAMEs from the sample matrix. Briefly, 0.5 mL of fat sample was transferred into
corresponding vials with 19.5 mL of DI water or desired solvent mix. Samples were then spiked
with 400 µl of 1 ppm (mg/L) of mirex as the internal standard. Finally, preconditioned GERSTEL
Twister® was added to each sample and all samples were set to stir for a pre-determined time at
pre-determined speed on a GERSTEL Twister stir plate. After stirring, each twister was removed
from solution with sterilized forceps and thoroughly rinsed with DI water. The twister was dried
with lint-free wipes and individually placed into Thermal Desorber 3.5+ (TD 3.5+) desorption tube
with glass frit. Sample was then analyzed by Thermal Desorber 3.5+ - Gas Chromatography /Mass
Spectrometry (TD 3.5+ - GC-MS).

Figure 4 Illustration of the SBSE extraction process for the analytes followed by GC-MS. A
sample containing the analytes (i.e. FAMEs) under investigation, as well as other
compounds that are part of the sample matrix, is placed in a vial. A GERSTEL
Twister® is then added to the solution to extract the desired analytes. After the
extraction is completed, the GERSTEL Twister® is placed on a desorption tube
followed by chemical analysis on a TD/GC-MS system.
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Chemical Analysis (TD 3.5+ - GC-MS)
After SBSE, the GERSTEL Twisters were removed and placed in a TD 3.5+ desorption
tube with glass frit. The desorption tube was then placed in a GERSTEL TD 3.5+ for the analysis
of FA methyl esters by GC-MS. Instrumental settings were as follows. TD 3.5+ initial temperature
was programmed to have an initial temperature of 50 °C and then ramp to a final temperature of
260 °C (held for 3 min) at a rate of 100 °C/min. The transfer line temperature was set at 300 °C.
During the thermal desorption, compounds were cryo-focused in a baffled glass liner CIS4 using
the GERSTEL Cooled Injection System (CIS) under liquid nitrogen at -40 °C (equilibration time
0.5min). Once desorption was completed, the CIS was heated from -40 to 300 °C (held for 1 min)
at a rate of 12 °C/s. The separation of all FAMEs analytes was completed on an Agilent
8890/5977B GC-MSD system (Agilent, CA, USA) fitted with a J&W HP-5MS ultra inert capillary
column (0.25 mm × 30 m × 0.25 um, Agilent, CA, USA). The GC oven was programmed to have
an initial temperature of 50°C which was first increased to 200 °C (held for 1 min) at a rate of
10°C/min, then the temperature was increased to 260 °C at a rate of 3 °C/min, and finally, the
temperature was increased to 300 °C (held for 5 min) at a rate of 10 °C/min. Ultra-high purity
helium was used as the carrier gas with a constant flow of 0.9 mL/min.

2.3 Statistical Analysis
T-test was performed using Microsoft Excel for Office 365 MSO to compare the means of
the number of FAMEs found under various conditions while studying transesterification. Tukey
test and ANOVA were performed using R to compare the recovery means of the 36 FAMEs across
different times and percentages of CH3OH.
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CHAPTER 3. RESULTS AND DISCUSSION
3.1 Sample Preparation
This section shows the results for the optimization of the transesterification process, for
which several factors were studied. For transesterification, we studied the temperature effect on
the formation of FAMEs (60-70 °C and 80-90 °C), as well as the effect of having different times
of duration for the overall reaction (1 hr vs 2 hrs), and finally, we studied different quantities of
the

acid

in

the

solvent

mixture

(10:1:1,

CH3OH:HCl:CHCl3,

v/v/v

and

10:3:1,

CH3OH:HCl:CHCl3, v/v/v). These conditions were studied using two available heating sources
which were a sonicator and an oven. The performance of each condition was evaluated by the
quantities of FAMEs which were determined by the instrument response on a GC-MS.

3.1.1 Transesterification
Two heating devices were used to determine the best transesterification temperatures for
the fat samples: an oven and a sonicator. The studied parameters were temperature,
transesterification time, and HCl ratio in the overall solvent mixture used for the transesterification.
A total of six different conditions were investigated, t1:T60-70:A1, t2:T60-70:A1, t1:T60-70:A3,
t2:T60-70:A3, t1:T80-90:A3, t2:T80-90:A3, where t stands for time, T stands for temperature, and
A for the HCl used in the solvent mixture (A1: 10:1:1, CH3OH:HCl:CHCl3, v/v/v, and A3: 10:3:1,
CH3OH:HCl:CHCl3, v/v/v)). Table 1 shows the number of FAMEs that were produced and
detected by the conditions under investigation. Data collection and analysis protocols were detailed
in Appendix 3. Only FAMEs that were identified by the library with a matching quality greater
than 50% were considered in the data analysis. Samples were run in triplicates for each variable
combination and the statistical analysis results are summarized in Appendix 4.
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In table 1a., which shows the number of FAMEs obtained after transesterification using a
sonicator for the reaction, the RSD (shown in parenthesis) of the different treatments was below
20%. Only one temperature setting was investigated using the sonicator (60-70 °C), due to the
limitation of the instrument. Two solvent mixtures, A1 (10:1:1, CH3OH:HCl:CHCl3, v/v/v) and
A3 (10:3:1, CH3OH:HCl:CHCl3, v/v/v), and two different transesterification times of 1hr and 2hrs
were investigated for the experiments. Overall, t2:T60-70:A1 and t1:T60-70:A3 demonstrated the
best performance to transesterify FAs into FAMEs. Using the t-test, we compared the resulting
number of FAMEs detected under each condition against each other, and there was no significant
difference between t1:T67:A1 and t2:T67:A1 (p=0.299), t1:T67:A1 and t1:T67:A3 (p=0.239),
t1:T67:A1 and t2:T67:A3(p=0.184), t2:T60-70:A1 and t1:T60-70:A3 (p=0.420), t2:T67:A1 and
t2:T67:A3 (p=0.059), as shown in Table 6 (Appendix 4). Nonetheless there was a significant
difference between t1:T60-70:A3 and t2:T60-70:A3 (p=0.003). We also noticed that that higher
HCl content, i.e. A3, produced a more consistent esterification, i.e. the RSD was decreased among
the sampled variables. As there is no significant difference between t2:T60-70:A1 and t1:T6070:A3, the transesterification reaction in a sonicator water bath at temperature of 60-70°C for one
hour (for a shorter reaction time) and the solvent mix A3 (i.e. t1:T60-70:A3) was chosen as the
optimized condition for transesterification when using the sonicator as the heating source.
Table 1 Number of FAMEs from the transesterification of pork fat stock solution under various
conditions. The two heat sources used for the formation of FAMEs were a) sonicator,
and b) oven. Tables show the average number of FAMEs ± standard deviation that
was detected after transesterification (n=3). The RSD is shown in parenthesis. The
numbers in red indicate that there is a significant difference between the two values.
a) Sonicator
Time (hr)
1
2
A

Temperature (°C)
60-70
18 ± 2.5 (14%) 20 ± 1.5 (8%)
21 ± 4.0 (20%) 16 ± 1.0 (6%)
1
3

b) Oven
Time (hr)
1
2
A
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Temperature (°C)
60-70
80-90
27 ± 5.7 (21%) 21 ± 2.3 (11%) 24 ± 2.3 (9%)
24 ± 2.3 (10%) 28 ± 4.9 (17%) 20 ± 1.0 (5 %)
1
3

Table 1b. shows the data obtained for transesterification using an oven for the reaction.
Two temperature variables were studied at 60-70 °C and 80-90 °C under the same solvent mixture
systems and times as those tested in the sonication experiment. The highest number of FAMEs
was produced under t2:T60-70:A3 followed by the results under t1:T60-70:A1. The higher
temperature did not favor the degree of transesterification. Based on the t-test, there was a
significant difference when comparing t1:T60-70:A3 to t2:T60-70:A3 (p=0.04); and no significant
difference among any of the other conditions. The results showed that the conditions of
temperature range 60-70 °C for two hours using the solvent mix A3 resulted in the greatest number
of FAMEs (28 ± 5).
We noticed that the heating in the oven may produce a more consistent heat transfer to the
reaction which, in turn, resulted in better transesterification of FAs into FAMEs. Table 1a had less
number of recovered FAMEs when compared to the conditions on table 1b. Nevertheless, the RSD
was lower for most of the conditions in Table 1a (t1:T67:A1, t1:T67:A3, t2:T67:A3) in contrast to
Table 1b, except for one condition ( t2:T67:A1). In regard to reaction time, the production of
FAMEs under 1 hour reaction time was generally equal to or better than the performance in 2 hours
using sonicator as shown in table 1a. As for the oven heating experiment, two hours of the reaction
was better for achieving a high number of FAMEs formed. This difference of time between the
oven and the sonicator could be due to the active mixing of the sample happening in the sonicator,
while in the oven the sample remains static through the heating process.
Overall a transesterification protocol was optimized for both the oven and the sonicator.
When comparing the number of FAMEs in obtained in the best condition of the sonicator (t1:T6070:A3) versus the best condition in the oven (t2:T60-70:A3) there was a significant difference
between both results (p=0.028). But for safety concerns, the sonicator was selected as the heating
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source of choice considering the volatility of the compounds used in the solvent mixture and the
acids used in the reaction. A sonicator can be placed inside of a fume hood, making it a safer
instrument to be used during the transesterification of FAs.

Overall based on the findings it was

decided that the condition for the optimal transesterification of FAs moving forward would be
maintaining a temperature between 60-70 °C for 1 hr using a solvent mixture of 10:3:1,
CH3OH:HCl:CHCl3, v/v/v using the sonicator.

3.2 FAMEs Extraction
After the esterification, FAMEs were extracted from the matrices prior to the chemical
analysis.

As showed in the schematic of Figure 1, the extraction of the FAMEs from the sample

was achieved using SBSE. SBSE was first introduced to the analytical world of extractions by
Baltussen et al. (1999). 42 The technique is solventless and acts to preconcentrate the analyte before
instrumental analysis. It is similar to solid-phase micro-extraction (SPME), which is also a solventfree sample preparation technique that includes the use of a solid sorbent in the form of a syringe
for the extraction of the analyte of interest from the sample.43 Nevertheless, the surface area
occupied by the polymer is larger in SBSE than that in SPME, allowing a higher amount of analyte
to be extracted. The theory behind the technique is based on the sorption of the analyte on to the
specific polymer coating the stir bar (twister). The extraction then depends on the octanol-water
partition coefficient (Ko/w, also expressed in Log scale, i.e. log P) of each specific analyte. SBSE
is used for the extraction of medium-polar and non-polar compounds. In general, the theoretical
extraction efficiency reaches 100% for solutes with log P greater than 2.7 (Figure 5).
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Figure 5 Recovery for solutes in the function of the octanol-water partitioning coefficient Ko/w
for SPME (10 mL sample, 0.5 μL PDMS) and for SBSE (10 mL sample, 100 μL
PDMS-fiber coated stir bar).42

To achieve the optimal extraction of a specific analyte, parameters such as the extraction
phase (twister coating), the sampling mode (direct immersion, or headspace), and other extraction
parameters (organic modifier or salt addition, pH adjustment, temperature, extraction time, stirring
speed during the extraction) have to be considered.

For this experiment, the extraction phase was

set to be Polydimethylsiloxane (PDMS) which is the type of stir bar available in the laboratory,
and the chosen sampling mode was direct immersion. A FAMEs standard containing 37 saturated
and unsaturated FAMEs was used for these experiments. Table 2 shows the list of the 37
compounds tested. The pH adjustment and temperature as extraction parameters were not studied.
In this section we studied the extraction parameters of solvent addition, stirring time, and stirring
speed.
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Table 2 List of the chemical and physical characteristics of both saturated and unsaturated from
the 37 FAMEs found in the standard solution. An explanation of how to read the
shorthand notation can be found in Figure 9 (Appendix 5).
37 FAMEs from standard

Molecular Formula

Shorthand notation

BP (760 mm Hg)

Butanoic acid, methyl ester

C5H10O2

C4:0

102.8

Log P
(Ko/w)
1.295

Hexanoic acid, methyl ester

C7H14O2

C6:0

149.5

2.314

Octanoic acid, methyl ester

C9H18O2

C8:0

192.9

3.333

Decanoic acid, methyl ester

C11H22O2

C10:0

224

4.352

Undecanoic acid, methyl ester

C12H24O2

C11:0

246

4.861

Dodecanoic acid, methyl ester

C13H26O2

C12:0

267

5.371

Tridecanoic acid, methyl ester

C14H28O2

C13:0

289.6

5.88

Methyl myristoleate

C15H28O2

C14:1 [cis-9]

306.6

5.98

Methyl tetradecanoate

C15H30O2

C14:0

295

6.39

Methyl (Z)-10-pentadecenoate

C16H30O2

C15:1 [cis-10]

320.9

6.49

Pentadecanoic acid, methyl ester

C16H32O2

C15:0

309.3

6.899

9-Hexadecenoic acid, methyl ester, (Z)-

C17H32O2

C16:1 [cis-9]

394.2

6.999

Hexadecanoic acid, methyl ester

C17H34O2

C16:0

332.1

7.409

cis-10-Heptadecenoic acid, methyl ester

C18H34O2

C17:1 [cis-10]

353.1

7.509

Heptadecanoic acid, methyl ester

C18H36O2

C17:0

337.1

7.918

Methyl .gamma.-linolenate

C19H32O2

C18:3 [cis-6,9,12]

385.4

7.111

9,12-Octadecadienoic acid, methyl ester, (E,E)-

C19H34O2

C18:2 [trans-9,12]

373.3

7.615

9,12-Octadecadienoic acid (Z,Z)-, methyl ester

C19H34O2

C18:2 [cis-9,12]

373.3

7.615

9-Octadecenoic acid, methyl ester, (E)-

C19H36O2

C18:1 [trans-9]

351.4

8.018

9-Octadecenoic acid (Z)-, methyl ester

C19H36O2

C18:1 [cis-9]

351.4

8.018

Methyl stearate

C19H38O2

C18:0

355.5

8.428

5,8,11,14-Eicosatetraenoic acid, methyl ester, (all-Z)-

C21H34O2

C20:4 [cis-5,8,11,14]

403.9

7.628

5,8,11,14,17-Eicosapentaenoic acid, methyl ester, (all-Z)-

C21H32O2

C20:5 [cis-5,8,11,14,17]

402.8

7.132

8,11,14-Eicosatrienoic acid, methyl ester, (Z,Z,Z)-

C21H36O2

C20:3 [cis-8,11,14]

405

8.138

cis-11,14-Eicosadienoic acid, methyl ester

C21H38O2

C20:2 [cis-11,14]

396.6

8.634

11,14,17-Eicosatrienoic acid, methyl ester

C21H36O2

C20:3 [cis-11,14,17]

398.9

8.138

Eicosanoic acid, methyl ester

C21H42O2

C20:0

375

9.447

cis-Methyl 11-eicosenoate

C21H40O2

C20:1 [cis-11]

394.3

9.037

9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)-

C19H32O2

C18:3 [cis-9,12,15]

364.4

7.119

Heneicosanoic acid, methyl ester

C22H44O2

C21:0

386.7

9.956

4,7,10,13,16,19-Docosahexaenoic acid, methyl ester, (all-Z)-

C23H34O2

C22:6 [cis-4,7,10,13,16,19]

429.9

7.645

cis-13,16-Docasadienoic acid, methyl ester

C23H42O2

C22:2 [cis-13,16]

425.1

9.653

13-Docosenoic acid, methyl ester, (Z)-

C23H44O2

C22:1 [cis-13]

422.9

10.056

Docosanoic acid, methyl ester

C23H46O2

C22:0 FAME

398

10.466

Tricosanoic acid, methyl ester

C24H48O2

C23:0

408.9

10.975

15-Tetracosenoic acid, methyl ester, (Z)-

C25H48O2

C24:1 [cis-15]

450.3

11.075

Tetracosanoic acid, methyl ester

C25H50O2

C24:0

419.5

11.485
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3.2.1 Solvent Addition and Stirring Time
Solvent addition and stirring time were analyzed together as possible variables that had the
capability of improving the extraction efficiency of FAMEs (Figure 6). The use of an organic
solvent in the sample matrix can increase the solubility of non-polar compounds (log p >3) by
minimizing the interaction of the analyte to the container (e.g. glass vial).42 Tables 4 & 5
(Appendix 1 & 2) show a detailed list of the physical and chemical characteristics of the FAMEs
analyzed in this project. The Log P (Ko/w) is a measurement that allows us to understand the
hydrophilicity of a compound. Since most of the FAMEs have a Log P>3, it was considered that
the use of an organic solvent would help to maximize the recovery of the analytes.

CH3OH was

the solvent of choice for these experiments. The addition of CH3OH to the sample matrix was
studied at 0%, 5%, 10%, and 30% of the total solvent composition. The statistical analysis of the
experiment is shown in Table 6 (Appendix 4). Results indicate that all CH3OH conditions were
significantly different as compared to 0% CH3OH. After looking at the peak area (i.e. the
instrument response) of each compound under every condition, it was concluded that the extraction
of most of the FAMEs from the matrix solution was achieved with better efficiency without adding
CH3OH to the extraction matrix. It could be due to the fact that CH3OH also increases the solubility
of FAMEs in the solvent, hence reduce the extraction of those compounds onto the stir bar.
Stirring time was also evaluated since it is known that extraction time plays an important
role in extraction effectiveness.42 In Figure 6 every CH3OH condition was evaluated at the stirring
times of 1 hr, 2 hr, 3 hr, 6 hr, and 12 hr. The effect of the studied variables was analyzed in each
of the compounds both individually and as a group. Figure 6a shows the response of each FAMEs
found in the sample while stirring for 1hr and having different percentages of CH3OH in the
extraction matrix. Figure 6a had the highest response for the majority of the compounds at 0%
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CH3OH. Figure 6b shows the response of each FAMEs found in the sample while stirring for 2 hrs
and having different percentages of CH3OH in the extraction matrix. Figure 6b had the highest
response at 0% CH3OH for the majority of the compounds. Figure 6c shows the response of each
FAMEs found in the sample while stirring for 3hr and having different percentages of CH3OH in
the extraction matrix. Figure 6c had a good response for small FAMEs chains through the samples
with different percentages of CH3OH, but the overall best response for the majority of the
compounds was at 0% CH3OH. Figure 6d shows the response of each FAMEs found in the sample
while stirring for 6hr and having different percentages of CH3OH in the extraction matrix. Figure
6d had the highest response for the majority of the compounds at 0% CH3OH. Figure 6e shows the
response of each FAMEs found in the sample while stirring for 12hr and having different
percentages of CH3OH in the extraction matrix. Figure 6e had the highest response for small chain
FAMEs at 30% CH3OH.
The statistical analysis summary can be found in Table 7 (Appendix 6). There was no
significant difference found for the majority of the compounds at different times, therefore out of
effectiveness the shortest time was selected as the condition for the extraction of FAMEs using
SBES. ANOVA results showed a significant difference between CH3OH and Stirring time,
meaning that the CH3OH contents had a significant difference in the extraction efficiency while
stirring times did not have much impact on the recovery.
After the statistical analysis and looking over the responses of the FAMEs through the
different variables, it was concluded that the best condition would be to have no CH3OH as part
of the sample matrix during SBSE. Also, it was concluded that 1hr would be the ideal time to
achieve a good response from all FAMEs being extracted from the sample while using SBSE.
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Figure 6 Comparison of FAMEs recoveries using SBSE across different stirring times and CH3OH
percentages. Each graph shows a stirring time for the extraction of each of the 36
FAMEs found in the standard stock solution, at times of a)1 hr, b)2 hrs, c)3 hrs, d)6
hrs, and e)12 hrs. The presence of different percentages of CH3OH (0%, 5%, 10%,
and 30%) in the extraction matrix was evaluated as a possible factor to increase the
recovery of FAMEs with Log P >3 (n=6).
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3.2.2 Stirring Speed
The stirring speed during extraction was analyzed as a possible variable to improve the
extraction efficiency of FAMEs. Based on previous results, 1 hour of stirring time was used in the
study of the effect of stirring speed on the recovery. To avoid excessive or too little agitation, the
studied speeds were 700, 1000, and 1500 RPM, which are normally the recommended speeds. 42
As shown in Figure 7, the recovery of each FAME compound was impacted by the different
stirring speeds. Also, it was observed that the recovery of smaller chains of FAMEs was higher
compared to the recovery of larger chains of FAMEs through all stirring speeds.

250,000,000

700 RPM

1000 RPM

1500 RPM

Response

200,000,000

150,000,000

100,000,000

-

C6:0
C8:0
C10:0
C11:0
C12:0
C13:0
C14:1 [cis-9]
C14:0
C15:1 [cis-10]
C15:0
C16:1 [cis-9]
C16:0
C17:1 [cis-10]
C17:0
C18:3 [cis-6,9,12]
C18:2 [trans-9,12]
C18:2 [cis-9,12]
C18:1 [trans-9]
C18:1 [cis-9]
C18:0
C20:4 [cis-…
C20:5 [cis-…
C20:3 [cis-8,11,14]
C20:2 [cis-11,14]
C20:3 [cis-…
C20:0
C20:1 [cis-11]
C18:3 [cis-9,12,15]
C21:0
C22:6 [cis-…
C22:2 [cis-13,16]
C22:1 [cis-13]
C22:0 FAME
C23:0
C24:1 [cis-15]
C24:0

50,000,000

Figure 7 Recovery of FAMEs using SBSE. The extraction was studied at 700 RPM, 1000 RPM,
1500 RPM for the duration of 1hour. (n=4)
Taking the average mean of the total response for the compounds at different stirring
speeds, a t-test looked at the statistical difference between these means. The statistical analysis
results in Table 3 showed that there was a large significant difference (p-value= 0.004) between
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using 700 RPM and 1500 RPM; also there was a slightly significant difference (p-value= 0.035)
between using 1000 RPM and 1500 RPM as stirring speed, but no significant difference (pvalue=0.182) between using 1000 RPM and 700 RPM as stirring speed. When looking at
individual compounds and comparing them through different stirring speeds Table 8 (Appendix 7)
it was observed that at higher speed (1500 RPM) promotes the recovery of long-chain FAMEs
from the sample.

Therefore, 1500 RPM was the stirring speed chosen for the method.

Table 3 Statistical analysis summary for stirring speed experiments. T-test showed that there was
a significant difference (p-value<0.05) between using 700 RPM or 1500 RPM, and
between 1000 RPM and 1500 RPM.
T-test (p-value)
RPM
700
1000

1000
0.182

1500
0.004
0.035

Finally, we attempted to use the optimized methodology to estimate the concentration of
the FAMEs extracted from pork fat. During SBSE procedures, 1 µL of the stock standard (at
2.6512×103 ppm, mg/L) was diluted in 20 mL of water giving the final concentration of the
solution at 0.132 ppm (mg/L). This concentration and the percent contribution of each of
FAMEs in the standard44 were then used to calculate the concentration of each FAMEs in
the SBSE solution. The response obtained from each extracted FAMEs was assumed to
account for 100% extraction efficacy for that compound. Using the relationship between
the concentration of each FAME in the standard solution and their instrument response, we were
then able to estimate the concentration of the FAMEs extracted from pork fat by doing a linear
extrapolation.
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Table 9 shows the calculated concentrations of FAMEs in the standard solution and the
instrument response, which is the area below the peak integrated by the instrument data analysis
software.

When analyzing the extract from port fat, we obtained the instrument responses of each

FAME, compared the response to the FAMEs in the standard, and roughly calculated the
concentration in the fat extract.

Our estimation showed that the FAMEs in the fat tissue have

concentrations from 0.18 ppb (µg/L) to 114.82 ppb (µg/L). The response of the FAME with the
lowest concentration was still very high (i.e. almost 3×106 counts). This allowed us to predict
that the limit of detection could be lower than 0.18 ppb (µg/L). This also indicated that we could
use much less amount of sample during transesterification from the current 10 mg fat tissue.

This

is a substantial attribute, especially when dealing with human tissue samples which often come
with a small amount available for the analysis. Thus, this estimate gives us the confidence that the
optimized method developed in this project could be a sensitive analytical tool for our future study
in PPAT in prostate cancer research.

Table 4 Estimated concentrations of the extracted FAMEs from pork fat. First, the concentration
for the standard solution was calculated for all FAMEs. These calculated
concentrations were then used to estimate (based on the response of the FAMEs
obtained from the sonicated pork fat) the concentration of the recovered FAMEs. The
concentrations detected ranged from 0.18 ppb (µg/L) to 114.82 ppb (µg/L).

FAMEs
Hexanoic acid, methyl ester
Octanoic acid, methyl ester
Decanoic acid, methyl ester
Dodecanoic acid, methyl ester
Methyl myristoleate
Methyl tetradecanoate
9-Hexadecenoic acid, methyl ester, (Z)Hexadecanoic acid, methyl ester
9-Octadecenoic acid, methyl ester, (E)Heptadecanoic acid, 16-methyl-, methyl ester

Extract from standard solution
Instrument
Calculated
Response
concentration
(Area)
(ppb)
56,942,599
5.28
137,232,460
5.28
112,324,947
5.28
130,969,624
5.28
44,306,252
2.64
126,446,694
5.28
18,854,006
2.64
127,111,517
7.92
26,213,122
2.64
46,358,035
5.28
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Extract from Pork fat
Instrument
Estimated
Response
concentration
(Area)
(ppb)
1,238,327,699
114.82
1,047,539,122
40.30
277,513,385
13.04
58,185,748
2.35
2,939,322
0.18
30,615,993
1.28
5,183,963
0.73
51,651,523
3.22
34,566,586
3.48
12,005,919
1.37

CHAPTER 4. CONCLUSIONS
This project developed a methodology for the transesterification and extraction of
FAMEs from adipose tissue as shown in Figure 9. Pork fat was used as the model adipose
tissue during the development of the methodology. For transesterification studies, the
variables studied were solvent mixture composition, transesterification time, and heating
method. Furthermore, for the improvement of the SBSE extraction process, the studied
variables were stirring time, stirring speed, and solvent composition.

Optimized Methodology
Homogenization (StS)
30 ml of HCl:CHCl3 (9:1,v:v) + 1 g of Freeze Dry Pork Fat

Transesterification (TS)
3 ml of CH3OH:HCl:CHCl3, 10:3:1 + 300 µL StS (i.e. 10 mg fat)
1 hr at 60-70 °C in Sonicator.

Extraction (SBSE)
19.5 ml DI H2O + 500 µL (TS) + 400 µL of 1ppm (mg/L) Mirex
1 hr Stirring Time at 1500 RPM
Figure 8 Diagram showing the steps for the optimized method for the analysis of FAs
in fat. StS: Stock sample after homogenization; TS: Transesterified
sample.
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Based on our results, we chose the solvent mixture CH3OH:HCl:CHCl3, 10:3:1
(v/v/v) as the solvent condition tested for the transesterification as it gave the most number
of FAs extracted from the fat while using the sonicator as the heating source for1 hr. The
transesterification could take place in either heating source, nevertheless, using the
sonicator was recommended over the oven for safety concern, since a sonicator could be
used inside the hood during transesterification of the samples to avoid the emission of
harmful chemical fumes.
For SBSE there was no significant difference found across different extraction times,
therefore it was decided that 1hr was the best stirring time to be used. There was a
significant difference found among various CH3OH contents, with 0% CH3OH giving the
highest recovery for the majority of the compounds.
These results from this study demonstrated a green chemistry approach for the analysis of
FAs (in forms of FAMEs) in adipose tissue samples. In contrast to previous methodologies, this
method used a solventless (i.e. green chemistry) extraction techniques by using SBSE. As
compared to the existing methods, the optimized method used no organic solvent and minimal
labor during the extraction process. Also, the sample size required for the developed methodology
was less (10 mg) than that reported in previously developed methodologies (15 – 1000 mg shown
in Figure 2).
Based on our estimation, the optimized method could be capable of detecting FAMEs at a
concentration below 0.18 ppb (µg/L).

The amount of fat tissue used in this study was 10 mg.

This finding indicated that we could potentially handle the analysis of FAs in a PPAT sample as
small as 1 mg or less. This will be an important benefit for this kind of study when the mass of
samples is limited.
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Overall, the project has laid a foundation for an easy, green, and sensitive method for the
analysis of FAs in fat tissue.

To our knowledge, it is the first methodology currently developed

that uses SBSE as the extraction technique.

For future improvement, we will continue working

on determining the linearity and the method detection limit.

In the future, this project could

become a tool to study the profile of FAs in PPAT for a better understanding of the role of FAs in
prostate cancer progression and aggressiveness.
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APPENDICES
APPENDIX 1
Table 5 Saturated FAMEs chemical and physical characteristics. The retention time (RT) for each
compound according to the developed methodology is also shown.
Saturated
FAMEs from
standard
Butanoic acid,
methyl ester
Hexanoic acid,
methyl ester
Octanoic acid,
methyl ester
Decanoic acid,
methyl ester
Undecanoic acid,
methyl ester
Dodecanoic acid,
methyl ester
Tridecanoic acid,
methyl ester
Methyl
tetradecanoate
Pentadecanoic
acid, methyl ester
Hexadecanoic
acid, methyl ester
Heptadecanoic
acid, methyl ester
Methyl stearate
Eicosanoic acid,
methyl ester
Heneicosanoic
acid, methyl ester
Docosanoic acid,
methyl ester
Tricosanoic acid,
methyl ester
Tetracosanoic
acid, methyl ester

CAS #

Molecular
Formula

#C

Shorthand
notation

BP (760 mm Hg)

Log P
(Ko/w)

623-42-7

C5H10O2

4

C4:0

102.8

1.295

000106-70-7

C7H14O2

6

C6:0

149.5

2.314

000111-11-5

C9H18O2

8

C8:0

192.9

3.333

000110-42-9

C11H22O2

10

C10:0

224

4.352

001731-86-8

C12H24O2

11

C11:0

246

4.861

000111-82-0

C13H26O2

12

C12:0

267

5.371

001731-88-0

C14H28O2

13

C13:0

289.6

5.88

000124-10-7

C15H30O2

14

C14:0

295

6.39

007132-64-1

C16H32O2

15

C15:0

309.3

6.899

000112-39-0

C17H34O2

16

C16:0

332.1

7.409

001731-92-6

C18H36O2

17

C17:0

337.1

7.918

000112-61-8

C19H38O2

18

C18:0

355.5

8.428

001120-28-1

C21H42O2

20

C20:0

375

9.447

6064-90-0

C22H44O2

21

C21:0

386.7

9.956

000929-77-1

C23H46O2

22

C22:0

398

10.466

002433-97-8

C24H48O2

23

C23:0

408.9

10.975

002442-49-1

C25H50O2

24

C24:0

419.5

11.485
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RT

8.31
12.20
15.25
16.59
17.86
19.04
20.18
21.44
22.90
24.57
26.44
30.62
32.85
35.13
37.41
39.67

APPENDIX 2
Table 6 Unsaturated FAMEs chemical and physical characteristics. The retention time (RT) for
each compound according to the developed methodology is also shown.
Unsaturared FAMEs
from standard
Methyl myristoleate
Methyl (Z)-10pentadecenoate
9-Hexadecenoic acid,
methyl ester, (Z)cis-10-Heptadecenoic
acid, methyl ester
Methyl .gamma.linolenate
9,12-Octadecadienoic
acid, methyl ester,
(E,E)9,12-Octadecadienoic
acid (Z,Z)-, methyl
ester
9-Octadecenoic acid,
methyl ester, (E)9-Octadecenoic acid
(Z)-, methyl ester
5,8,11,14Eicosatetraenoic acid,
methyl ester, (all-Z)5,8,11,14,17Eicosapentaenoic acid,
methyl ester, (all-Z)8,11,14-Eicosatrienoic
acid, methyl ester,
(Z,Z,Z)cis-11,14Eicosadienoic acid,
methyl ester
11,14,17Eicosatrienoic acid,
methyl ester
cis-Methyl 11eicosenoate
9,12,15Octadecatrienoic acid,
methyl ester, (Z,Z,Z)4,7,10,13,16,19Docosahexaenoic acid,
methyl ester, (all-Z)cis-13,16Docasadienoic acid,
methyl ester
13-Docosenoic acid,
methyl ester, (Z)15-Tetracosenoic acid,
methyl ester, (Z)-

CAS #

Molecular
Formula

#C

Shorthand
notation

056219-06-8

C15H28O2

14

C14:1

1000426-92-2

C16H30O2

15

C15:1

001120-25-8

C17H32O2

16

C16:1

1000333-62-1

C18H34O2

17

C17:1

016326-32-2

C19H32O2

18

C18:3

002566-97-4

C19H34O2

18

C18:2

000112-63-0

C19H34O2

18

C19H36O2

18

C18:1

000112-62-9

C19H36O2

18

C18:1

002566-89-4

C21H34O2

20

C20:4

021061-10-9
1000333-61-8
055682-88-7

C21H32O2
C21H36O2
C21H38O2
C21H36O2

20
20
20
20

C20:5

C20:1

000301-00-8

C19H32O2

18

C18:3

1000333-60-3

C23H42O2

22

mono

[cis-9]

mono

[cis-10]

mono

[cis-6,9,12]

poly

[trans-9,12]

poly

[cis-9,12]

poly

[trans-9]

mono

[cis-9]

mono

[cis-5,8,11,14]

poly

[cis5,8,11,14,17]

poly

[cis-8,11,14]

poly

[cis-11,14]

poly

C20:3

20

22

[cis-10]

C20:2

C21H40O2

C23H34O2

mono

C20:3

002390-09-2

2566-90-7

[cis-9]

C18:2

001937-62-8

002734-47-6

Unsaturations

C22:6

[cis-11,14,17]

poly

[cis-11]

mono

[cis-9,12,15]

poly

[cis4,7,10,13,16,19]

C23H44O2

22

C22:1

002733-88-2

C25H48O2

24

C24:1

37

Log P
(Ko/w)

306.6

5.98

320.9

6.49

394.2

6.999

353.1

7.509

385.4

7.111

373.3

7.615

373.3

7.615

351.4

8.018

351.4

8.018

403.9

7.628

402.8

7.132

405

8.138

396.6

8.634

398.9

8.138

394.3

9.037

364.4

7.119

429.9

7.645

425.1

9.653

422.9

10.056

450.3

11.075

poly

C22:2

001120-34-9

BP (760
mm Hg)

[cis-13,16]

poly

[cis-13]

mono

[cis-15]

mono

RT

20.05
21.29
22.60
24.23
25.56
25.85
25.85
25.97
26.08
29.18
29.33
29.56
29.96
30.11
30.07
30.11
33.41
34.46
34.54
39.12

APPENDIX 3
Protocol for Data Analysis of Transesterification Experiments
1.

Data Extraction from the Chromatogram.
i.

Instrument Analysis

ii.

File<Load the File

iii.

Integrate

iv.

Spectrum<Percent Report

v.

Chromatography<Library Search Report

2.

Filter the Extracted Data.
i.

Copy the data from the GC-MS computer to the Excel.

ii.

Organize the data by peak number, retention time, area, library, CAS, and quality.

iii.

Filter Mirex and methyl esters from data.

iv.

Deal with the replicated compounds
⚫

Find out the compound with the highest quality.

⚫

Delete the compound(s) with quality <10% of that of the highest quality peak.

⚫

Consider the retention time. If the difference between the retention times of peaks
identified with the same CAS# is more than 0.5s, delete the one with lower quality
and keep the one with higher quality (when the qualities are the same, keep the one
with higher amount of area).

⚫

Mark in the compound list of the sample, the compound(s) which can be found in
empty TDT and control samples. Then delete the compound in the sample list, if it
has the same area, as the compound from empty TDT or control.

v.

Look over the quality and the retention time of every methyl ester, then delete those which
have the quality <50%.

vi.

Count the number of methyl esters of every sample.
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APPENDIX 4
Table 7 Statistical analysis summary for transesterification experiments. Temperature (T), time
(t), and HCl (A) amount in the solvent mix were the studied variables. The studied
variables were a) t1:T60-70:A1, b) t2:T60-70:A1, c) t1:T60-70:A3, d) t2:T60-70:A3,
e) t1:T80-90:A3, f)t2:T80-90:A3. T-test showed a significant difference (pvalue<0.05) when comparing c vs d in both oven and sonicator.
Studied
variables
a vs b
a vs c
a vs d
a vs e
a vs f
b vs c
b vs d
b vs e
b vs f
c vs d
c vs e
c vs f
d vs e
d vs f
e vs f

T-test (p-value)
Sonication
Oven
0.299
0.225
0.239
0.160
0.184
0.386
0.322
0.067
0.420
0.162
0.059
0.190
0.333
0.064
0.003
0.041
0.055
0.377
0.191
0.053
0.072
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APPENDIX 5

Figure 9 This figure gives a short explanation of the shorthand notation used for naming FAMEs.
The number after C represents the number of carbons present on the chain (this
including the methyl group present on the ester side). The next number represents the
degree of unsaturation of specific FAME. The next portion on the brackets gives
further specifications about the unsaturations present in the carbon chain. If the
unsaturations are on a cis or trans mode, and where are the unsaturations located
throughout the chain. The FAME structure showed on the white box was obtained
from PubChem.31
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Mirex
000106-70-7 Hexanoic acid, methyl ester
000111-11-5 Octanoic acid, methyl ester
000110-42-9 Decanoic acid, methyl ester
001731-86-8 Undecanoic acid, methyl ester
000111-82-0 Dodecanoic acid, methyl ester
001731-88-0 Tridecanoic acid, methyl ester
056219-06-8 Methyl myristoleate
000124-10-7 Methyl tetradecanoate
1000426-92-2 Methyl (Z)-10-pentadecenoate
007132-64-1 Pentadecanoic acid, methyl ester
001120-25-8 9-Hexadecenoic acid, methyl ester, (Z)000112-39-0 Hexadecanoic acid, methyl ester
1000333-62-1 cis-10-Heptadecenoic acid, methyl ester
001731-92-6 Heptadecanoic acid, methyl ester
016326-32-2 Methyl .gamma.-linolenate
002566-97-4 9,12-Octadecadienoic acid, methyl ester, (E,E)000112-63-0 9,12-Octadecadienoic acid (Z,Z)-, methyl ester
001937-62-8 9-Octadecenoic acid, methyl ester, (E)000112-62-9 9-Octadecenoic acid (Z)-, methyl ester
Methyl stearate
5,8,11,14-Eicosatetraenoic acid, methyl ester, (all-Z)5,8,11,14,17-Eicosapentaenoic acid, methyl ester, (all-Z)021061-10-9 8,11,14-Eicosatrienoic acid, methyl ester, (Z,Z,Z)1000333-61-8 cis-11,14-Eicosadienoic acid, methyl ester
055682-88-7 11,14,17-Eicosatrienoic acid, methyl ester
001120-28-1 Eicosanoic acid, methyl ester
002390-09-2 cis-Methyl 11-eicosenoate
000301-00-8 9,12,15-Octadecatrienoic acid, methyl ester, (Z,Z,Z)Heneicosanoic acid, methyl ester
4,7,10,13,16,19-Docosahexaenoic acid, methyl ester, (all-Z)1000333-60-3 cis-13,16-Docasadienoic acid, methyl ester
001120-34-9 13-Docosenoic acid, methyl ester, (Z)000929-77-1 Docosanoic acid, methyl ester
002433-97-8 Tricosanoic acid, methyl ester
15-Tetracosenoic acid, methyl ester, (Z)002442-49-1 Tetracosanoic acid, methyl ester

Name
0.05-0% 0.1-0%
0.0356 0.0592
1.0000 0.3820
0.8710 0.9990
0.3100 0.1230
0.9310 0.6170
0.6500 0.2470
0.0540 0.0131
0.0005 0.0003
0.0023 0.0007
0.0008 0.0004
0.0011 0.0005
0.0018 0.0017
0.0021 0.0013
0.0018 0.0017
0.0007 0.0005
0.0123 0.0115
0.0014 0.0013
0.0015 0.0015
0.0004 0.0003
0.0008 0.0007
0.0023 0.0017
0.0016 0.0016
0.0019 0.0019
0.0012 0.0012
0.0006 0.0006
0.0011 0.0011
0.0008 0.0005
0.0005 0.0004
0.0115 0.0108
0.0005 0.0005
0.0012 0.0013
0.0007 0.0007
0.0008 0.0008
0.0006 0.0005
0.0008 0.0007
0.0020 0.0022
0.0024 0.0023

Tukey test (p-value)
ANOVA f-value
MeOH
Time
0.3-0% 0.1-0.05% 0.3-0.05% 0.3-0.1% 1 to 12 2 to 12
3 to 12
6 to 12 2 to 1 3 to 1 6 to 1 3 to 2
6 to 2
6 to 3
MeOH
Time
0.7910
0.9910
0.1680 0.2620 0.9530
0.2900
1.0000
0.7100 0.0999 0.9460 0.3340 0.3030 0.9250 0.7270 0.0220
0.0990
0.0293
0.4180
0.0331 0.4080 0.8690
0.3450
0.9990
0.9820 0.8540 0.9440 0.9920 0.4550 0.6310 0.9980 0.3670
0.0199
0.8940
0.8200
0.4870 0.9330 0.7150
0.0685
0.9980
0.9660 0.4510 0.5380 0.9670 0.0405 0.1900 0.8740 0.0428
0.5578
0.5100
0.9260
0.9770 0.7450 0.5450
0.0233
1.0000
0.9860 0.2920 0.4670 0.8230 0.0182 0.0550 0.9640 0.0144
0.1486
0.9990
0.9170
0.8740 0.5270 0.0973
0.0130
0.9900
0.6180 0.7610 0.2000 0.6660 0.0286 0.1470 0.8590 0.0099
0.5157
0.9500
0.8510
0.9140 0.4930 0.0461
0.0049
0.9960
0.6270 0.6900 0.0841 0.4090 0.0090 0.0553 0.8220 0.0029
0.2738
0.1560
0.8490
0.9170 0.4950 0.0080
0.0050
0.9090
0.6030 0.9990 0.0342 0.0958 0.0214 0.0608 0.9710 0.0018
0.0162
0.0006
0.9970
0.9990 0.9850 0.9990
0.9970
0.7480
0.7250 0.6020 0.5780 0.8980 0.8820 1.0000 0.4653 0.0001
0.0000
0.0070
0.8860
0.9080 0.5280 0.0053
0.0047
0.7890
0.9560 1.0000 0.0366 0.0171 0.0323 0.0150 0.9910 0.0010
0.0006
0.0007
0.9860
1.0000 0.9940 1.0000
1.0000
0.8620
0.7010 1.0000 0.8500 0.6840 0.8900 0.7380 0.9970 0.5559
0.0002
0.0014
0.9630
0.9990 0.9280 0.6400
0.9230
1.0000
0.8940 0.9740 0.6820 0.2130 0.9440 0.4670 0.8640 0.2593
0.0003
0.0020
1.0000
1.0000 0.9990 0.9990
0.8510
0.8430
0.4880 0.9420 0.9380 0.6350 1.0000 0.9600 0.9640 0.5022
0.0006
0.0023
0.9910
1.0000 0.9830 0.8260
0.9980
0.9980
0.7060 0.9360 0.6630 0.1990 0.9740 0.5410 0.8600 0.2749
0.0006
0.0019
1.0000
1.0000 1.0000 0.9850
0.7000
0.7780
0.4300 0.9310 0.9660 0.7180 1.0000 0.9880 0.9690 0.4614
0.0006
0.0004
0.9930
0.9850 1.0000 0.9980
0.7380
0.7550
0.4630 0.8740 0.8860 0.6210 1.0000 0.9870 0.9840 0.4351
0.0002
0.0125
1.0000
1.0000 1.0000 0.9870
0.7980
0.9150
0.6970 0.5270 0.6870 0.4250 0.9990 1.0000 0.9890 0.3746
0.0052
0.0014
1.0000
1.0000 1.0000 0.9650
0.7210
0.7270
0.4290 0.9700 0.9720 0.7850 1.0000 0.9830 0.9820 0.4798
0.0005
0.0015
1.0000
1.0000 1.0000 0.8990
0.6260
0.6350
0.3890 0.9810 0.9830 0.8610 1.0000 0.9920 0.9910 0.4387
0.0005
0.0003
0.9960
0.9960 1.0000 1.0000
0.9940
0.7970
0.6090 0.9990 0.8660 0.6950 0.9500 0.8280 0.9970 0.5510
0.0001
0.0007
1.0000
1.0000 1.0000 0.8880
0.7140
0.5960
0.4340 0.9960 0.9780 0.9070 1.0000 0.9860 0.9980 0.4799
0.0002
0.0013
0.9980
0.9860 0.9980 0.9780
0.8180
0.7940
0.3550 0.9850 0.9790 0.6580 1.0000 0.9070 0.9230 0.4332
0.0006
0.0018
1.0000
1.0000 1.0000 0.9210
0.5050
0.7220
0.3740 0.9200 0.9910 0.8170 0.9950 0.9990 0.9670 0.3971
0.0006
0.0020
1.0000
1.0000 1.0000 0.9520
0.5560
0.7780
0.3810 0.9130 0.9910 0.7690 0.9940 0.9970 0.9480 0.4112
0.0007
0.0012
1.0000
1.0000 1.0000 0.8940
0.4980
0.6660
0.3840 0.9390 0.9900 0.8630 0.9980 0.9990 0.9840 0.4031
0.0004
0.0006
1.0000
1.0000 1.0000 0.5600
0.5530
0.5810
0.4350 1.0000 1.0000 0.9990 1.0000 0.9990 0.9990 0.4313
0.0002
0.0011
1.0000
1.0000 1.0000 0.8980
0.5000
0.6610
0.3820 0.9370 0.9880 0.8570 0.9980 0.9990 0.9850 0.4008
0.0004
0.0004
0.9890
0.9550 0.9970 0.7580
0.3380
0.5600
0.4120 0.9330 0.9960 0.9690 0.9920 1.0000 0.9990 0.3497
0.0002
0.0004
1.0000
1.0000 1.0000 0.6640
0.4840
0.4010
0.5800 0.9980 0.9880 1.0000 1.0000 1.0000 0.9970 0.4111
0.0001
0.0111
1.0000
1.0000 1.0000 1.0000
0.5150
0.7880
0.5600 0.5150 0.7890 0.5610 0.9870 1.0000 0.9940 0.3276
0.0048
0.0004
1.0000
0.9980 0.9990 0.6910
0.3250
0.5810
0.4080 0.9560 1.0000 0.9850 0.9860 1.0000 0.9980 0.3463
0.0002
0.0014
1.0000
1.0000 1.0000 0.8910
0.3060
0.6500
0.4060 0.7840 0.9880 0.8840 0.9620 0.9990 0.9910 0.3168
0.0004
0.0006
1.0000
1.0000 1.0000 0.7090
0.4350
0.5040
0.4450 0.9870 0.9960 0.9890 1.0000 1.0000 1.0000 0.3970
0.0002
0.0007
1.0000
1.0000 1.0000 0.8290
0.3560
0.5510
0.4640 0.9000 0.9850 0.9610 0.9950 0.9990 1.0000 0.3678
0.0003
0.0004
1.0000
0.9960 0.9990 0.8250
0.2490
0.5190
0.4620 0.7890 0.9790 0.9620 0.9760 0.9880 1.0000 0.2925
0.0002
0.0006
1.0000
0.9980 0.9990 0.8210
0.2350
0.5150
0.5500 0.7730 0.9790 0.9870 0.9710 0.9590 1.0000 0.2979
0.0002
0.0019
1.0000
1.0000 1.0000 0.9420
0.3840
0.7000
0.4550 0.7910 0.9790 0.8570 0.9770 1.0000 0.9200 0.3696
0.0007
0.0020
1.0000
1.0000 1.0000 0.8720
0.7800
0.5330
0.4180 1.0000 0.9660 0.9100 0.9910 0.9630 0.9990 0.4555
0.0008

APPENDIX 6

Table 8 Statistical analysis summary for SBSE stirring time and solvent addition experiments.
ANOVA test showed a significant difference (f-value<0.05) between CH3OH and
time. Tukey test showed that there was no significant difference between different
times, nevertheless, there was a significant difference (p-value<0.05) among different
percentages of CH3OH in the sample matrix.
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APPENDIX 7
Table 9 Recovery value of FAMEs while using different stirring velocities during SBSE. (n=4)
Stirring speed (RPM)
FAMEs
1,000

1,500

C6:0

71,792,185

700

66,105,725

56,942,599

C8:0

153,789,251

180,594,424

137,232,460

C10:0

137,856,983

163,132,981

112,324,947

C11:0

99,618,114

119,911,065

74,711,739

C12:0

165,414,181

187,356,252

130,969,624

C13:0

94,927,677

103,690,270

86,496,856

C14:1 [cis-9]

41,287,039

45,188,887

44,306,252

C14:0

123,689,337

130,914,201

126,446,694

C15:1 [cis-10]

30,944,218

32,715,415

34,031,592

C15:0

52,523,223

57,166,874

58,960,583

C16:1 [cis-9]

16,118,929

17,366,558

18,854,006

C16:0

109,738,907

117,621,937

127,111,517

C17:1 [cis-10]

10,858,534

12,096,793

13,305,543

C17:0

26,821,387

27,481,563

32,721,734

C18:3 [cis-6,9,12]

9,336,847

10,026,374

10,887,375

C18:2 [trans-9,12]

8,110,943

8,593,242

9,876,008

C18:2 [cis-9,12]

8,108,528

8,597,122

9,873,233

C18:1 [trans-9]

21,875,117

22,814,655

26,213,122

C18:1 [cis-9]

6,816,435

7,187,783

8,343,793

C18:0

39,768,756

39,531,534

46,358,035

C20:4 [cis-5,8,11,14]

2,243,014

2,558,067

2,918,057

C20:5 [cis-5,8,11,14,17]

2,733,338

3,097,456

3,365,965

C20:3 [cis-8,11,14]

1,870,817

1,999,924

2,421,500

C20:2 [cis-11,14]

2,020,182

2,061,451

2,658,158

C20:3 [cis-11,14,17]

2,183,866

2,277,628

2,853,186

C20:0

10,649,261

9,292,889

12,635,276

C20:1 [cis-11]

3,328,205

3,207,304

4,157,989

C18:3 [cis-9,12,15]

2,196,454

2,291,266

2,844,454

C21:0

2,126,241

2,101,508

2,627,311

C22:6 [cis-4,7,10,13,16,19]

212,950

298,726

297,671

C22:2 [cis-13,16]

294,758

388,928

406,951

C22:1 [cis-13]

530,839

607,473

710,978

C22:0 FAME

2,823,635

2,982,855

3,488,113

C23:0

676,044

800,420

884,778

C24:1 [cis-15]

192,013

222,667

229,946

C24:0

1,463,715

1,661,083

1,781,791
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